Management of Adrenal Insufficiency Risk After Long-term Systemic Glucocorticoid Therapy in Duchenne Muscular Dystrophy: Clinical Practice Recommendations

Long-term glucocorticoid therapy has improved outcomes in patients with Duchenne muscular dystrophy. However, the recommended glucocorticoid dosage suppresses the hypothalamic-pituitary-adrenal axis, leading to adrenal insufficiency that may develop during severe illness, trauma or surgery, and afte...

Descripción completa

Detalles Bibliográficos
Autores principales: Bowden, Sasigarn A., Connolly, Anne M., Kinnett, Kathi, Zeitler, Philip S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398538/
https://www.ncbi.nlm.nih.gov/pubmed/30614808
http://dx.doi.org/10.3233/JND-180346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398538/
https://www.ncbi.nlm.nih.gov/pubmed/30614808
http://dx.doi.org/10.3233/JND-180346

Ejemplares similares